Clinical trial
Interplay Between Immune and Metabolic Programs in Myelodysplastic Syndromes: Involvement in Leukemia Transformation and Therapeutic Targeting
NCT04803721 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interplay Between Immune and Metabolic Programs in Myelodysplastic Syndromes: Involvement in Leukemia Transformation and Therapeutic Targeting
- Lead sponsor
- University Hospital, Toulouse
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 23, 2021
- Completion date
- January 1, 2024
- Enrollment
- 137 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.